Boehringer Ingleheim Takes Biggest Price Increases In 2005, AARP Report Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Increases for respiratory inhalers Atrovent and Combivent contributed to 17% average price growth in 2005 for BI’s major products, according to AARP “Rx Watchdog Report.”